COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review and meta-analysis

JW Senefeld, M Franchini, C Mengoli… - JAMA Network …, 2023 - jamanetwork.com
Importance Patients who are immunocompromised have increased risk for morbidity and
mortality associated with coronavirus disease 2019 (COVID-19) because they less …

COVID-19: challenges of viral variants

JL Jacobs, G Haidar, JW Mellors - Annual Review of Medicine, 2023 - annualreviews.org
The COVID-19 pandemic has been accompanied by SARS-CoV-2 evolution and
emergence of viral variants that have far exceeded initial expectations. Five major variants of …

Immunologic interplay between HIV/AIDS and COVID-19: adding fuel to the flames?

M Augello, V Bono, R Rovito, C Tincati… - Current HIV/AIDS …, 2023 - Springer
Abstract Purpose of Review HIV/AIDS and COVID-19 have been the major pandemics
overwhelming our times. Given the enduring immune disfunction featuring people living with …

The severity of COVID-19 across the spectrum of HIV

KW Miller, RT Gandhi - Current Opinion in HIV and AIDS, 2023 - journals.lww.com
People with HIV have faced increased challenges during the COVID-19 pandemic because
of high rates of comorbidities and social determinants of health as well as the impact of HIV …

[HTML][HTML] Prolonged SARS-CoV-2 infection successfully treated with a consecutive combined scheme therapy in an HIV-positive patient with AIDS

A Vergori, F Baldini, C Pinnetti, S Grisetti, A Mondi… - 2023 - europepmc.org
Purpose: Cases of persistent infection have already been widely described with some
proposals for combination or extended course therapies in immunocompromised subjects …

[PDF][PDF] 12. HIV and COVID-19

C HOFFMANN - Janssen-Cilag MSD ViiV Healthcare - hivbuch.de
At the end of October 2022, more than 35 million SARS-CoV-2 infections were reported in
Germany. Suppose one considers the high number of unreported cases or cases not …